Brg1 regulates the transcription of human papillomavirus type 18 E6 and E7 genes

Cell Cycle

Volumn 11, Issue 3, 2012, Pages 617-627

  He, Hongpeng ^a   Luo, Yan ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Brg1; Derepression; E6 and E7; Human papillomaviruses; P53; Protein accumulation; Rb; Tip60; Transcription

Indexed keywords

BRG1 PROTEIN; BRM PROTEIN; PROTEIN P300; PROTEIN P53; RETINOBLASTOMA PROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR JUNB; VIRUS DNA;

ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DOWN REGULATION; E6 GENE; E7 GENE; GENE CONTROL; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; NONHUMAN; PROTEIN BINDING; TRANSCRIPTION REGULATION; VIRUS ONCOGENE;

EID: 84857217104     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.3.19115     Document Type: Article

References (55)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27; PMID:15183049; http://dx.doi.org/10.1016/j.virol.2004.03.033.
2. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009; 384:260-5; PMID:19135222; http://dx.doi.org/10.1016/j.virol.2008.11.046.
3. Kadaja M, Silla T, Ustav E, Ustav M. Papillomavirus DNA replication-from initiation to genomic instability. Virology 2009; 384:360-8; PMID:19141359; http://dx.doi.org/10.1016/j.virol.2008.11.032.
4. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75:495-505; PMID:8221889; http://dx.doi.org/10.1016/0092- 8674(93)90384-3.
5. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B, Tommasino M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010; 40:1-13; PMID:19838783; http://dx.doi.org/10.1007/s11262-009- 0412-8.
6. Sanduja S, Dixon DA. Tristetraprolin and E6-AP: Killing the messenger in cervical cancer. Cell Cycle 2010; 9:3135-6; PMID:20865819; http://dx.doi.org/10. 4161/cc.9.16.12951.
7. Wang J, Sampath A, Raychaudhuri P, Bagchi S. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene 2001; 20:4740-9; PMID:11498796; http://dx.doi.org/10.1038/sj.onc. 1204655.
8. Huh K, Zhou X, Hayakawa H, Cho JY, Libermann TA, Jin J, et al. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol 2007; 81:9737-47; PMID:17609271; http://dx.doi.org/10.1128/ JVI.00881-07.
9. Thierry F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009; 384:375-9; PMID:19064276; http://dx.doi.org/10.1016/j.virol.2008.11.014.
10. Bednarek PH, Lee BJ, Gandhi S, Lee E, Phillips B. Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting. J Virol 1998; 72:708-16; PMID:9420277.
11. Bouallaga I, Teissier S, Yaniv M, Thierry F. HMGI(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity. Mol Cell Biol 2003; 23:2329-40; PMID:12640118; http://dx.doi.org/10.1128/MCB.23.7.2329-40.2003.
12. Mohrmann L, Verrijzer CP. Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta 2005; 1681:59-73; PMID:15627498.
13. Hassan AH, Neely KE, Vignali M, Reese JC, Workman JL. Promoter targeting of chromatinmodifying complexes. Front Biosci 2001; 6:1054-64; PMID:11532604; http://dx.doi.org/10.2741/Hassan.
14. Katsani KR, Mahmoudi T, Verrijzer CP. Selective gene regulation by SWI/SNF-related chromatin remodeling factors. Curr Top Microbiol Immunol 2003; 274:113-41; PMID:12596906; http://dx.doi.org/10.1007/978-3-642-55747-7-5.
15. Belotserkovskaya R, Berger SL. Interplay between chromatin modifying and remodeling complexes in transcriptional regulation. Crit Rev Eukaryot Gene Expr 1999; 9:221-30; PMID:10651239.
16. Martens JA, Winston F. Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 2003; 13:136-42; PMID:12672490; http://dx.doi.org/10.1016/S0959-437X(03)00022-4.
17. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 1994; 79:119-30; PMID:7923370; http://dx.doi.org/10.1016/ 0092-8674(94)90405-7.
18. Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci USA 1997; 94:11268-73; PMID:9326598; http://dx.doi.org/10.1073/pnas.94.21.11268.
19. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101:79-89; PMID:10778858; http://dx.doi.org/10.1016/S0092-8674(00)80625-X.
20. Hendricks KB, Shanahan F, Lees E. Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 2004; 24:362-76; PMID:14673169; http://dx.doi.org/10.1128/MCB.24.1.362-76.2004.
21. Kang H, Cui K, Zhao K. BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol 2004; 24:1188-99; PMID:14729964; http://dx.doi.org/10.1128/MCB.24.3.1188-99.2004.
22. Miliani de Marval PL, Zhang Y. The RP-Mdm2-p53 pathway and tumorigenesis. Oncotarget 2011; 2:234-8; PMID:21406728.
23. Ye Y, Xiao Y, Wang W, Wang Q, Yearsley K, Wani AA, et al. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition and cancer cell death. Mol Cancer Res 2009; 7:1984-99; PMID:19996304; http://dx.doi.org/10.1158/1541-7786.MCR-09-0119.
24. Sheu JJ, Guan B, Choi JH, Lin A, Lee CH, Hsiao YT, et al. Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. J Biol Chem 2010; 285:38260-9; PMID:20923775; http://dx.doi.org/10. 1074/jbc.M110.138735.
25. Smeenk G, Wiegant WW, Vrolijk H, Solari AP, Pastink A, van Attikum H. The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damage. J Cell Biol 2010; 190:741-9; PMID:20805320; http://dx.doi.org/10.1083/jcb. 201001048.
26. Xu Y, Zhang J, Chen X. The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J Biol Chem 2007; 282:37429-35; PMID:17938176; http://dx.doi.org/10.1074/jbc.M706039200.
27. Garcia-Carranca A, Thierry F, Yaniv M. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J Virol 1988; 62:4321-30; PMID:2845145.
28. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000; 64:435-59; PMID:10839822; http://dx.doi.org/10.1128/MMBR.64.2.435-59.2000.
29. Bouallaga I, Massicard S, Yaniv M, Thierry F. An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription. EMBO Rep 2000; 1:422-7; PMID:11258482; http://dx.doi.org/10. 1093/emboreports/kvd091.
30. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005; 113:951-60; PMID:15514944; http://dx.doi.org/10.1002/ijc.20668.
31. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 2011; 10:39; PMID:21496227; http://dx.doi.org/10.1186/1476-4598-10-39.
32. Medina-Martinez O, Morales-Peza N, Yaniv M, García-Carrancá A, Thierry F. A single element mediates glucocorticoid hormone response of HPV18 with no functional interactions with AP1 or hbrm. Virology 1996; 217:392-6; PMID:8599228; http://dx.doi.org/10.1006/viro.1996.0129.
33. Henderson A, Holloway A, Reeves R, Tremethick DJ. Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol Cell Biol 2004; 24:389-97; PMID:14673171; http://dx.doi.org/10.1128/MCB.24.1.389-97.2004.
34. Narayanan K, Srinivas R, Peterson MC, Ramachandran A, Hao J, Thimmapaya B, et al. Transcriptional regulation of dentin matrix protein 1 by JunB and p300 during osteoblast differentiation. J Biol Chem 2004; 279:44294-302; PMID:15308641; http://dx.doi.org/10.1074/jbc.M403511200.
35. Sun Y, Jiang X, Price BD. Tip60: connecting chromatin to DNA damage signaling. Cell Cycle 2010; 9:930-6; PMID:20160506; http://dx.doi.org/10.4161/ cc.9.5.10931.
36. Jha S, Vande Pol S, Banerjee NS, Dutta AB, Chow LT, Dutta A. Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. Mol Cell 2010; 38:700-11; PMID:20542002; http://dx.doi.org/10.1016/j.molcel.2010.05.020.
37. Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene 2009; 28:1653-68; PMID:19234488; http://dx.doi.org/10.1038/onc.2009.4.
38. Dai C, Gu W. p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 2010; 16:528-36; PMID:20932800; http://dx.doi.org/10.1016/j.molmed.2010.09.002.
39. Muñoz-Fontela C, González D, Marcos-Villar L, Campagna M, Gallego P, González-Santamaría J, et al. Acetylation is indispensable for p53 antiviral activity. Cell Cycle 2011; 10:3701-5; PMID:22033337; http://dx.doi.org/10.4161/cc.10.21.17899.
40. Roe JS, Kim HR, Hwang IY, Ha NC, Kim ST, Cho EJ, et al. Phosphorylation of von Hippel-Lindau protein by checkpoint kinase 2 regulates p53 transactivation. Cell Cycle 2011; 10:3920-8; PMID:22071692; http://dx.doi.org/ 10.4161/cc.10.22.18096.
41. Stindt MH, Carter S, Vigneron AM, Ryan KM, Vousden KH. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. Cell Cycle 2011; 10:3176-88; PMID:21900752; http://dx.doi.org/10.4161/cc.10.18.17436.
42. Knappskog S, Lønning PE. MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk. Oncotarget 2011; 2:251-8; PMID:21436469.
43. Trinh DL, Elwi AN, Kim SW. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis. Oncotarget 2010; 1:396-404; PMID:21311096.
44. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92:690-8; PMID:10793105; http://dx.doi.org/10.1093/jnci/92.9.690.
45. Thierry F, Spyrou G, Yaniv M, Howley P. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 1992; 66:3740-8; PMID:1316480.
46. Parker JN, Zhao W, Askins KJ, Broker TR, Chow LT. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ 1997; 8:751-62; PMID:9218869.
47. Bauknecht T, Angel P, Royer HD, zur Hausen H. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J 1992; 11:4607-17; PMID:1330541.
48. Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade JD, et al. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 2003; 1:343-62; PMID:15046258; http://dx.doi.org/10.2174/ 1570162033485186.
49. Naidu SR, Love IM, Imbalzano AN, Grossman SR, Androphy EJ. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 2009; 28:2492-501; PMID:19448667; http://dx.doi.org/10.1038/onc.2009.121.
50. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003; 15:164-71; PMID:12648672; http://dx.doi.org/10.1016/S0955-0674(03)00003-6.
51. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4:793-805; PMID:15510160; http://dx.doi.org/10.1038/ nrc1455.
52. Carter S, Vousden KH. Modifications of p53: competing for the lysines. Curr Opin Genet Dev 2009; 19:18-24; PMID:19179064; http://dx.doi.org/10.1016/j. gde.2008.11.010.
53. DeRan M, Pulvino M, Greene E, Su C, Zhao J. Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition. Mol Cell Biol 2008; 28:435-47; PMID:17967892; http://dx.doi.org/10.1128/MCB.00607-07.
54. He H, Yu FX, Sun C, Luo Y. CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. PLoS One 2011; 6:22088; PMID:21789216; http://dx.doi.org/10.1371/journal.pone.0022088.
55. +/NADH redox signaling regulates coordinated histone expression and S-phase progression. Cell Cycle 2009; 8:773-9; PMID:19221488; http://dx.doi.org/10.4161/cc.8.5.7880.